1. Home
  2. SLNO vs PLXS Comparison

SLNO vs PLXS Comparison

Compare SLNO & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • PLXS
  • Stock Information
  • Founded
  • SLNO 1999
  • PLXS 1979
  • Country
  • SLNO United States
  • PLXS United States
  • Employees
  • SLNO N/A
  • PLXS N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PLXS Electrical Products
  • Sector
  • SLNO Health Care
  • PLXS Technology
  • Exchange
  • SLNO Nasdaq
  • PLXS Nasdaq
  • Market Cap
  • SLNO 3.8B
  • PLXS 3.6B
  • IPO Year
  • SLNO 2014
  • PLXS 1986
  • Fundamental
  • Price
  • SLNO $79.98
  • PLXS $130.72
  • Analyst Decision
  • SLNO Strong Buy
  • PLXS Buy
  • Analyst Count
  • SLNO 9
  • PLXS 4
  • Target Price
  • SLNO $103.33
  • PLXS $157.33
  • AVG Volume (30 Days)
  • SLNO 662.7K
  • PLXS 123.6K
  • Earning Date
  • SLNO 08-06-2025
  • PLXS 07-23-2025
  • Dividend Yield
  • SLNO N/A
  • PLXS N/A
  • EPS Growth
  • SLNO N/A
  • PLXS 41.85
  • EPS
  • SLNO N/A
  • PLXS 5.14
  • Revenue
  • SLNO N/A
  • PLXS $3,967,612,000.00
  • Revenue This Year
  • SLNO N/A
  • PLXS $4.62
  • Revenue Next Year
  • SLNO N/A
  • PLXS $9.00
  • P/E Ratio
  • SLNO N/A
  • PLXS $25.41
  • Revenue Growth
  • SLNO N/A
  • PLXS N/A
  • 52 Week Low
  • SLNO $36.93
  • PLXS $100.96
  • 52 Week High
  • SLNO $81.54
  • PLXS $172.89
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 60.77
  • PLXS 48.73
  • Support Level
  • SLNO $76.14
  • PLXS $130.24
  • Resistance Level
  • SLNO $81.54
  • PLXS $133.11
  • Average True Range (ATR)
  • SLNO 2.49
  • PLXS 2.29
  • MACD
  • SLNO 0.00
  • PLXS -0.50
  • Stochastic Oscillator
  • SLNO 81.81
  • PLXS 23.55

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About PLXS Plexus Corp.

Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.

Share on Social Networks: